10.24335/L17561
RoyaltyStat
Research collaboration to develop and market compounds to treat ophthalmic diseases, with exclusive patent and technology license to use, distribute, sell, make, and have made compounds which block glutamate-activated ion channels, including NMDA channels, and subclasses of sodium channels, and therapeutic compositions incorporating the compounds.
RoyaltyStat
1996